Rankings
▼
Calendar
PRGO Q2 2021 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q2 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$981M
+3.4% YoY
Gross Profit
$349M
35.6% margin
Operating Income
-$126M
-12.8% margin
Net Income
-$58M
-5.9% margin
EPS (Diluted)
$-0.43
QoQ Revenue Growth
-2.9%
Cash Flow
Operating Cash Flow
-$82M
Free Cash Flow
-$176M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$11.2B
Total Liabilities
$5.7B
Stockholders' Equity
$5.5B
Cash & Equivalents
$318M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$981M
$949M
+3.4%
Gross Profit
$349M
$347M
+0.5%
Operating Income
-$126M
$63M
-300.8%
Net Income
-$58M
$61M
-195.2%
Revenue Segments
Consumer Self-Care Americas
$622M
63%
Consumer Self-Care International
$359M
37%
Geographic Segments
UNITED STATES
$590M
60%
Europe
$348M
35%
Other Geographical Areas
$43M
4%
IRELAND
$5M
1%
← FY 2021
All Quarters
Q3 2021 →